Inozyme Pharma
INZY
#9457
Rank
A$92.57 M
Marketcap
$1.44
Share price
-3.20%
Change (1 day)
-83.87%
Change (1 year)

Inozyme Pharma (INZY) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.10 Billion

According to Inozyme Pharma's latest financial reports the company's total liabilities are A$0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inozyme Pharma - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.10 B18.58%
2023-12-31A$88.6 M189.88%
2022-12-31A$30.56 M55.26%
2021-12-31A$19.68 M34.44%
2020-12-31A$14.64 M-87.37%
2019-12-31A$0.11 B42.23%
2018-12-31A$81.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$51.08 M-52.54%๐Ÿ‡บ๐Ÿ‡ธ USA